A citation-based method for searching scientific literature

Matthew W Segar, Kershaw V Patel, Muthiah Vaduganathan, Melissa C Caughey, Byron C Jaeger, Mujeeb Basit, Duwayne Willett, Javed Butler, Partho P Sengupta, Thomas J Wang, Darren K McGuire, Ambarish Pandey. Diabetologia 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
Aidin Rawshani, Araz Rawshani, Stefan Franzén, Björn Eliasson, Ann-Marie Svensson, Mervete Miftaraj, Darren K McGuire, Naveed Sattar, Annika Rosengren, Soffia Gudbjörnsdottir. N Engl J Med 2017
482
100

Latent Autoimmune Diabetes of Adults (LADA) Is Likely to Represent a Mixed Population of Autoimmune (Type 1) and Nonautoimmune (Type 2) Diabetes.
Angus G Jones, Timothy J McDonald, Beverley M Shields, William Hagopian, Andrew T Hattersley. Diabetes Care 2021
3
100

Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes.
Robert Wagner, Martin Heni, Adam G Tabák, Jürgen Machann, Fritz Schick, Elko Randrianarisoa, Martin Hrabě de Angelis, Andreas L Birkenfeld, Norbert Stefan, Andreas Peter,[...]. Nat Med 2021
26
100

Stratification of type 2 diabetes based on routine clinical markers.
Narges Safai, Ashfaq Ali, Peter Rossing, Martin Ridderstråle. Diabetes Res Clin Pract 2018
20
100

Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update.
Lorraine Lipscombe, Sonia Butalia, Kaberi Dasgupta, Dean T Eurich, Lori MacCallum, Baiju R Shah, Scot Simpson, Peter A Senior. Can J Diabetes 2020
22
100

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
100

Effects of intensive blood-pressure control in type 2 diabetes mellitus.
William C Cushman, Gregory W Evans, Robert P Byington, David C Goff, Richard H Grimm, Jeffrey A Cutler, Denise G Simons-Morton, Jan N Basile, Marshall A Corson, Jeffrey L Probstfield,[...]. N Engl J Med 2010
100

Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype.
Eberhard Standl, Susanna R Stevens, Paul W Armstrong, John B Buse, Juliana C N Chan, Jennifer B Green, John M Lachin, Andre Scheen, Florence Travert, Frans Van de Werf,[...]. Diabetes Care 2018
43
100

Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
100

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
100

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
Adrian F Hernandez, Jennifer B Green, Salim Janmohamed, Ralph B D'Agostino, Christopher B Granger, Nigel P Jones, Lawrence A Leiter, Anne E Rosenberg, Kristina N Sigmon, Matthew C Somerville,[...]. Lancet 2018
634
100

Metformin monotherapy for adults with type 2 diabetes mellitus.
Filip Gnesin, Anne Cathrine Baun Thuesen, Lise Katrine Aronsen Kähler, Sten Madsbad, Bianca Hemmingsen. Cochrane Database Syst Rev 2020
7
100

Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data.
John M Dennis, Beverley M Shields, William E Henley, Angus G Jones, Andrew T Hattersley. Lancet Diabetes Endocrinol 2019
90
100

Factors Associated with Risk of Diabetic Complications in Novel Cluster-Based Diabetes Subgroups: A Japanese Retrospective Cohort Study.
Hayato Tanabe, Haruka Saito, Akihiro Kudo, Noritaka Machii, Hiroyuki Hirai, Gulinu Maimaituxun, Kenichi Tanaka, Hiroaki Masuzaki, Tsuyoshi Watanabe, Koichi Asahi,[...]. J Clin Med 2020
14
100

Identification of type 2 diabetes subgroups through topological analysis of patient similarity.
Li Li, Wei-Yi Cheng, Benjamin S Glicksberg, Omri Gottesman, Ronald Tamler, Rong Chen, Erwin P Bottinger, Joel T Dudley. Sci Transl Med 2015
200
100

Alogliptin after acute coronary syndrome in patients with type 2 diabetes.
William B White, Christopher P Cannon, Simon R Heller, Steven E Nissen, Richard M Bergenstal, George L Bakris, Alfonso T Perez, Penny R Fleck, Cyrus R Mehta, Stuart Kupfer,[...]. N Engl J Med 2013
100

Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.
Rena R Wing, Paula Bolin, Frederick L Brancati, George A Bray, Jeanne M Clark, Mace Coday, Richard S Crow, Jeffrey M Curtis, Caitlin M Egan, Mark A Espeland,[...]. N Engl J Med 2013
100

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
Francesco Cosentino, Peter J Grant, Victor Aboyans, Clifford J Bailey, Antonio Ceriello, Victoria Delgado, Massimo Federici, Gerasimos Filippatos, Diederick E Grobbee, Tina Birgitte Hansen,[...]. Eur Heart J 2020
100

Validation of distinct type 2 diabetes clusters and their association with diabetes complications in the DEVOTE, LEADER and SUSTAIN-6 cardiovascular outcomes trials.
Anna R Kahkoska, Milan S Geybels, Klara R Klein, Frederik F Kreiner, Nikolaus Marx, Michael A Nauck, Richard E Pratley, Benjamin O Wolthers, John B Buse. Diabetes Obes Metab 2020
16
100

Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: a data-driven cluster analysis: the INSPIRED study.
Ranjit Mohan Anjana, Viswanathan Baskar, Anand Thakarakkattil Narayanan Nair, Saravanan Jebarani, Moneeza Kalhan Siddiqui, Rajendra Pradeepa, Ranjit Unnikrishnan, Colin Palmer, Ewan Pearson, Viswanathan Mohan. BMJ Open Diabetes Res Care 2020
22
100

Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes.
Christopher P Cannon, Richard Pratley, Samuel Dagogo-Jack, James Mancuso, Susan Huyck, Urszula Masiukiewicz, Bernard Charbonnel, Robert Frederich, Silvina Gallo, Francesco Cosentino,[...]. N Engl J Med 2020
289
100

Patient clusters based on HbA1c trajectories: A step toward individualized medicine in type 2 diabetes.
Tomas Karpati, Maya Leventer-Roberts, Becca Feldman, Chandra Cohen-Stavi, Itamar Raz, Ran Balicer. PLoS One 2018
10
100

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Jennifer B Green, M Angelyn Bethel, Paul W Armstrong, John B Buse, Samuel S Engel, Jyotsna Garg, Robert Josse, Keith D Kaufman, Joerg Koglin, Scott Korn,[...]. N Engl J Med 2015
100

Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke.
Subodh Verma, Neil R Poulter, Deepak L Bhatt, Stephen C Bain, John B Buse, Lawrence A Leiter, Michael A Nauck, Richard E Pratley, Bernard Zinman, David D Ørsted,[...]. Circulation 2018
45
100

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata, Ayesha A Motala, Katherine Ogurtsova,[...]. Diabetes Res Clin Pract 2019
100

Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables.
Emma Ahlqvist, Petter Storm, Annemari Käräjämäki, Mats Martinell, Mozhgan Dorkhan, Annelie Carlsson, Petter Vikman, Rashmi B Prasad, Dina Mansour Aly, Peter Almgren,[...]. Lancet Diabetes Endocrinol 2018
606
100



Effects of combination lipid therapy in type 2 diabetes mellitus.
Henry N Ginsberg, Marshall B Elam, Laura C Lovato, John R Crouse, Lawrence A Leiter, Peter Linz, William T Friedewald, John B Buse, Hertzel C Gerstein, Jeffrey Probstfield,[...]. N Engl J Med 2010
100

Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study.
Oana P Zaharia, Klaus Strassburger, Alexander Strom, Gidon J Bönhof, Yanislava Karusheva, Sofia Antoniou, Kálmán Bódis, Daniel F Markgraf, Volker Burkart, Karsten Müssig,[...]. Lancet Diabetes Endocrinol 2019
107
100

Clusters of people with type 2 diabetes in the general population: unsupervised machine learning approach using national surveys in Latin America and the Caribbean.
Rodrigo M Carrillo-Larco, Manuel Castillo-Cara, Cecilia Anza-Ramirez, Antonio Bernabé-Ortiz. BMJ Open Diabetes Res Care 2021
1
100

A randomized trial of therapies for type 2 diabetes and coronary artery disease.
Robert L Frye, Phyllis August, Maria Mori Brooks, Regina M Hardison, Sheryl F Kelsey, Joan M MacGregor, Trevor J Orchard, Bernard R Chaitman, Saul M Genuth, Suzanne H Goldberg,[...]. N Engl J Med 2009
100


Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
100

Clinical characterization of data-driven diabetes subgroups in Mexicans using a reproducible machine learning approach.
Omar Yaxmehen Bello-Chavolla, Jessica Paola Bahena-López, Arsenio Vargas-Vázquez, Neftali Eduardo Antonio-Villa, Alejandro Márquez-Salinas, Carlos A Fermín-Martínez, Rosalba Rojas, Roopa Mehta, Ivette Cruz-Bautista, Sergio Hernández-Jiménez,[...]. BMJ Open Diabetes Res Care 2020
8
100

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, Peter Carson, James Januzzi, Subodh Verma, Hiroyuki Tsutsui, Martina Brueckmann,[...]. N Engl J Med 2020
736
100

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Mansoor Husain, Andreas L Birkenfeld, Morten Donsmark, Kathleen Dungan, Freddy G Eliaschewitz, Denise R Franco, Ole K Jeppesen, Ildiko Lingvay, Ofri Mosenzon, Sue D Pedersen,[...]. N Engl J Med 2019
434
100

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
100

Clinical Implications of Echocardiographic Phenotypes of Patients With Diabetes Mellitus.
Laura Ernande, Etienne Audureau, Christine L Jellis, Cyrille Bergerot, Corneliu Henegar, Daigo Sawaki, Gabor Czibik, Chiara Volpi, Florence Canoui-Poitrine, Hélène Thibault,[...]. J Am Coll Cardiol 2017
66
100

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Rury R Holman, M Angelyn Bethel, Robert J Mentz, Vivian P Thompson, Yuliya Lokhnygina, John B Buse, Juliana C Chan, Jasmine Choi, Stephanie M Gustavson, Nayyar Iqbal,[...]. N Engl J Med 2017
829
100

Machine Learning and Data Mining Methods in Diabetes Research.
Ioannis Kavakiotis, Olga Tsave, Athanasios Salifoglou, Nicos Maglaveras, Ioannis Vlahavas, Ioanna Chouvarda. Comput Struct Biotechnol J 2017
151
100

Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial.
Julio Rosenstock, Steven E Kahn, Odd Erik Johansen, Bernard Zinman, Mark A Espeland, Hans J Woerle, Egon Pfarr, Annett Keller, Michaela Mattheus, David Baanstra,[...]. JAMA 2019
193
100

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Hertzel C Gerstein, Helen M Colhoun, Gilles R Dagenais, Rafael Diaz, Mark Lakshmanan, Prem Pais, Jeffrey Probstfield, Jeffrey S Riesmeyer, Matthew C Riddle, Lars Rydén,[...]. Lancet 2019
700
100

Agreement among cardiovascular disease risk calculators.
G Michael Allan, Faeze Nouri, Christina Korownyk, Michael R Kolber, Ben Vandermeer, James McCormack. Circulation 2013
66
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.